Talisman

Lupita Nyong'o, Danielle Brooks and Simu Liu Shine in De Beers at the 2024 Academy Awards

Retrieved on: 
Monday, March 11, 2024

LOS ANGELES, March 11, 2024 /PRNewswire/ -- De Beers Jewellers natural & ethically sourced diamond jewelry dazzled on Lupita Nyong'o, Danielle Brooks and Simu Liu, at the 96th annual Academy Awards held at Dolby Theatre in Los Angeles, CA.

Key Points: 
  • LOS ANGELES, March 11, 2024 /PRNewswire/ -- De Beers Jewellers natural & ethically sourced diamond jewelry dazzled on Lupita Nyong'o, Danielle Brooks and Simu Liu, at the 96th annual Academy Awards held at Dolby Theatre in Los Angeles, CA.
  • Actor Simu Liu looked dapper on the Oscars red carpet with the unexpected styling and unique placement of the 'Imaginary Nature' diamond high jewelry brooch on his tuxedo.
  • De Beers looks at the 96th Academy Awards include:
    De Beers Thames Path earrings, set in 18K White Gold, 7.52 carats.
  • De Beers Diamond Legends by De Beers, Cupid Cocktail Ring, set in 18k White Gold, 6.44 carats.

FilterLabs.AI Unveils Talisman--AI-Powered Insights using Hyper-Local Data and Natural Language Processing

Retrieved on: 
Friday, March 1, 2024

CAMBRIDGE, Mass., March 1, 2024 /PRNewswire-PRWeb/ -- FilterLabs.AI, a provider of cutting-edge data intelligence and analysis applications, proudly introduces its latest innovative product, Talisman. This powerful addition to the company's suite of solutions is designed to equip businesses and organizations with AI-enhanced insights driven by hyper-local data and powered by natural language processing, revolutionizing the way organizations analyze information and communicate their messages.

Key Points: 
  • FilterLabs.AI, a provider of cutting-edge data intelligence and analysis applications, proudly introduces its latest innovation product, Talisman.
  • This powerful addition to the company's suite of solutions is designed to equip businesses and organizations with AI-enhanced insights driven by hyper-local data and powered by natural language processing, revolutionizing the way organizations analyze information and communicate their messages.
  • CAMBRIDGE, Mass., March 1, 2024 /PRNewswire-PRWeb/ -- FilterLabs.AI, a provider of cutting-edge data intelligence and analysis applications, proudly introduces its latest innovative product, Talisman.
  • This powerful addition to the company's suite of solutions is designed to equip businesses and organizations with AI-enhanced insights driven by hyper-local data and powered by natural language processing, revolutionizing the way organizations analyze information and communicate their messages.

Wilson Elser Strengthens Miami Team with Three Leading Women Litigators

Retrieved on: 
Wednesday, January 17, 2024

NEW YORK, Jan. 17, 2024 /PRNewswire/ -- National law firm Wilson Elser announced today that it has hired three leading attorneys in its Miami, Florida, office.

Key Points: 
  • NEW YORK, Jan. 17, 2024 /PRNewswire/ -- National law firm Wilson Elser announced today that it has hired three leading attorneys in its Miami, Florida, office.
  • The new attorneys bring years of litigation and trial experience to bolster the firm's prowess in the South Florida region.
  • "I am thrilled to welcome Rachel, Amy and Regina to Wilson Elser," said Sean M. McDonough, regional managing partner of Wilson Elser's Miami and Orlando, Florida, offices.
  • Rachel Walters is a Board Certified Civil Trial lawyer with almost 20 years of litigation experience.

AcelRx Announces Rebranding With Name Change to Talphera, Inc.

Retrieved on: 
Tuesday, January 9, 2024

SAN MATEO, Calif., Jan. 9, 2024 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the rebranding of the Company, with a name change to Talphera, Inc. ("Talphera"). The rebrand decision was made to reflect the Company's strategy of developing and commercializing products to support advancing care to optimize outcomes in medically supervised settings, moving beyond the original focus on acute pain.  The Company's lead nafamostat product candidate, Niyad, is expected to have a Premarket Approval (PMA) submission to the FDA in the second half of 2024.  

Key Points: 
  • The name Talphera was derived from "Talisman", meaning a strong leader, and reflects the new "pharmaceutical era" for the Company.
  • The company's new mission at Talphera is to support healthcare providers by developing and commercializing products in medically supervised settings that deliver advances in care to patients.
  • Talphera will commence trading on the Nasdaq Global Market under the ticker symbol "TLPH" effective January 10, 2024.
  • A PMA submission for Niyad is expected to be filed with the FDA in the second half of 2024.

Cineverse Reports Second Quarter Fiscal Year 2024 Results

Retrieved on: 
Tuesday, November 14, 2023

LOS ANGELES, Nov. 14, 2023 /PRNewswire/ -- Cineverse Corp. ("Cineverse" or the "Company") (NASDAQ: CNVS), a global streaming technology and entertainment company, today announced its financial results for the fiscal second quarter ended September 30, 2023 ("Q2 FY 2024"). 

Key Points: 
  • Operating Expenses Decreased by $6.3 Million, or 34%
    Adjusted EBITDA Increased by $3.7 Million, or 283%, to $2.4 Million
    LOS ANGELES, Nov. 14, 2023 /PRNewswire/ -- Cineverse Corp. ("Cineverse" or the "Company") (NASDAQ: CNVS), a global streaming technology and entertainment company, today announced its financial results for the fiscal second quarter ended September 30, 2023 ("Q2 FY 2024").
  • Q2 FY 2024 Highlights (all comparisons are to the prior year fiscal quarter ended September 30, 2022):
    During the Quarter, the Company's initiatives to reduce operating costs, optimize our streaming channel portfolio and increase margins had a very positive impact on our financial results.
  • Last quarter, the Company launched Cineverse Services India ("Cineverse Services"), a new business unit that expands upon the Company's successful India operations to consolidate Cineverse's support operations at vastly reduced costs.
  • ET today (Tuesday, November 14, 2023), during which management will discuss the results of the fiscal second quarter ended September 30, 2023.

STEP Energy Services Ltd. Announces Appointment of New Independent Director Edward Lafehr and Retirement of Jason Skehar

Retrieved on: 
Thursday, November 2, 2023

CALGARY, Alberta, Nov. 01, 2023 (GLOBE NEWSWIRE) -- STEP Energy Services Ltd. (“STEP”) is pleased to announce the appointment of Mr. Edward LaFehr as an independent director of STEP’s board of directors, effective November 1, 2023.

Key Points: 
  • CALGARY, Alberta, Nov. 01, 2023 (GLOBE NEWSWIRE) -- STEP Energy Services Ltd. (“STEP”) is pleased to announce the appointment of Mr. Edward LaFehr as an independent director of STEP’s board of directors, effective November 1, 2023.
  • Mr. LaFehr has 40 years of experience in the energy industry managing large and complex onshore and offshore E&P assets.
  • Mr. LaFehr previously served as the president and chief executive officer of Baytex Energy Corporation for six years.
  • STEP’s director, Ms. Evelyn Angelle, also assumed the position of lead director for STEP’s board of directors.

Phillips-Medisize Teams with GlucoModicum to Develop an Innovative Needle-Free Continuous Glucose Monitor

Retrieved on: 
Tuesday, October 3, 2023

"We wanted to create a solution that is needle free, accurate and more affordable so people would better monitor their glucose," said Jokke Mäki, managing director of GlucoModicum.

Key Points: 
  • "We wanted to create a solution that is needle free, accurate and more affordable so people would better monitor their glucose," said Jokke Mäki, managing director of GlucoModicum.
  • "Working with Phillips-Medisize, we applied compelling science to develop a world-class product that may help billions of people better manage their diabetes."
  • While their scientists conducted rigorous research, GlucoModicum sought an experienced contract development and manufacturing organization (CDMO) to assist in realizing their vision for a new device, called Talisman.
  • Together, the companies are also beginning to explore other potential uses of this innovative technology to support management of other diseases.

Cineverse Horror Channel SCREAMBOX TV Launches on Amazon Freevee

Retrieved on: 
Thursday, September 7, 2023

LOS ANGELES, Sept. 7, 2023 /PRNewswire/ -- Cineverse Corp. (NASDAQ: CNVS), a global streaming technology and entertainment company with one of the world's largest portfolios of streaming channels and content libraries, today announced the launch of its popular horror channel, SCREAMBOX TV, on Amazon Freevee. 

Key Points: 
  • LOS ANGELES, Sept. 7, 2023 /PRNewswire/ -- Cineverse Corp. (NASDAQ: CNVS), a global streaming technology and entertainment company with one of the world's largest portfolios of streaming channels and content libraries, today announced the launch of its popular horror channel, SCREAMBOX TV, on Amazon Freevee.
  • The free ad-supported streaming television (FAST) channel joins others from Cineverse's portfolio of streaming brands that were previously added to the Freevee line-up, including The Bob Ross Channel, The Dove Channel, Midnight Pulp, the Nacelle Pop Channel, RealMadrid TV and RetroCrush.
  • SCREAMBOX has become the premier streaming brand in horror and the fastest growing in the genre.
  • "We're thrilled to bring the thrills of SCREAMBOX TV to an even wider audience with our launch as a FAST channel on Amazon Freevee," said Tom Owen, Managing Director, Bloody Disgusting/Cineverse.

EQS-News: Advanced Blockchain announces new project

Retrieved on: 
Tuesday, May 9, 2023

Mai 2023 - Advanced Blockchain AG (“AB”, Scale Frankfurt, primary market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator, architect and investor for the blockchain industry, announces its latest product innovation: AB Capital AI.

Key Points: 
  • Mai 2023 - Advanced Blockchain AG (“AB”, Scale Frankfurt, primary market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator, architect and investor for the blockchain industry, announces its latest product innovation: AB Capital AI.
  • This revolutionary product is a data aggregator that employs state-of-the-art AI technology to deliver automated token selection and research.
  • peaq also integrated with Fetch.ai for AI-based process automation, and Fraunhofer-led AI project will store EV battery digital twins on peaq network.
  • The Panoptic team participated in the Cornell Blockchain conference and held a well-received public event where they showcased their product demo.

Cinedigm Acquires All North American Rights to the Sundance Film Festival 2023 Midnight Section Favorite

Retrieved on: 
Wednesday, April 26, 2023

LOS ANGELES, April 26, 2023 /PRNewswire/ -- Cinedigm has acquired all North American rights to the buzzed-about horror-comedy Onyx the Fortuitous and the Talisman of Souls. The film premiered at the Sundance Film Festival 2023 Midnight Section to rave reviews, recently played at Fright Fest at the Glasgow Film Festival and the Calgary Underground Film Festival and will continue its festival run at the Chattanooga Film Festival, the Dark Bridges Film Festival and Fantasia International. Cinedigm plans to release the film in theaters this fall followed by an exclusive launch on the Company's horror streaming service SCREAMBOX.

Key Points: 
  • The film premiered at the Sundance Film Festival 2023 Midnight Section to rave reviews, recently played at Fright Fest at the Glasgow Film Festival and the Calgary Underground Film Festival and will continue its festival run at the Chattanooga Film Festival, the Dark Bridges Film Festival and Fantasia International.
  • Cinedigm plans to release the film in theaters this fall followed by an exclusive launch on the Company's horror streaming service SCREAMBOX.
  • Misunderstood by all who know him, Marcus J. Trillbury (Bowser), aka Onyx the Fortuitous, is struggling to find purpose in his soul-devouring side gig.
  • SCREAMBOX recently acquired the docuseries "RoboDoc: The Creation of RoboCop" and the documentary film "Hollywood Dreams and Nightmares: The Robert Englund Story".